Literature DB >> 22529734

Effect of ribavirin on hepatitis A virus replication in vitro.

R K Chaudhary1, A P Andonov.   

Abstract

The effect of ribavirin on fetal Rhesus monkey kidney cells (FRhK-4) acutely or chronically infected with hepatitis A virus was studied. The effect of ribavirin on hepatitis A virus yield as detected by radioimmunoassay in acutely infected FRhK-4 cells was dependent on hepatitis A virus inoculum dose. Treatment with 100 μg/mL ribavirin completely inhibited hepatitis A virus growth in cultures infected with 100 to 800 tissue culture infectious dose 50 (TCID(50)) hepatitis A virus, but inocula of 800 to 1600 TCID(50) resulted in limited production of virus. The effect was time dependent and required more than 96 h of treatment to inhibit the virus completely. Ribavirin was less effective in treating cells persistently infected with hepatitis A virus, although there was significant inhibition of hepatitis A virus (82%) in persistently infected cells as well. Ribavirin had some inhibitory effect on cell growth; treatment with 25, 50 or 100 μg/mL ribavirin reduced cell growth by approximately 0, 20 and 40%, respectively.

Entities:  

Keywords:  Hepatitis A; Radioimmunoassay; Ribavirin

Year:  1992        PMID: 22529734      PMCID: PMC3328025          DOI: 10.1155/1992/531837

Source DB:  PubMed          Journal:  Can J Infect Dis        ISSN: 1180-2332


  8 in total

1.  Influence of twenty potentially antiviral substances on in vitro multiplication of hepatitis A virus.

Authors:  A Widell; B G Hansson; B Oberg; E Nordenfelt
Journal:  Antiviral Res       Date:  1986-03       Impact factor: 5.970

2.  Efficacy, toxicology and clinical applications of ribavirin against virulent RNA viral infections.

Authors:  P G Canonico
Journal:  Antiviral Res       Date:  1985       Impact factor: 5.970

3.  Detection of hepatitis A virus by a modified commercial radioimmunoassay.

Authors:  R K Chaudhary
Journal:  Am J Clin Pathol       Date:  1984-03       Impact factor: 2.493

4.  Prophylactic efficacy of immune serum globulin against hepatitis A.

Authors:  H Ohara; I Ebisawa; S Ohtani
Journal:  Jpn J Exp Med       Date:  1986-10

5.  Ribavirin cures cells of a persistent infection with foot-and-mouth disease virus in vitro.

Authors:  J C de la Torre; B Alarcón; E Martínez-Salas; L Carrasco; E Domingo
Journal:  J Virol       Date:  1987-01       Impact factor: 5.103

6.  Effects of ribavirin on BHK-21 cells acutely or persistently infected with mumps virus.

Authors:  J R McCammon; V W Riesser
Journal:  Antimicrob Agents Chemother       Date:  1979-03       Impact factor: 5.191

7.  Failure of guanidine and 2-(alpha-hydroxybenzyl)benzimidazole to inhibit replication of hepatitis A virus in vitro.

Authors:  G Siegl; H J Eggers
Journal:  J Gen Virol       Date:  1982-07       Impact factor: 3.891

8.  Aerosolized ribavirin treatment of infants with respiratory syncytial viral infection. A randomized double-blind study.

Authors:  C B Hall; J T McBride; E E Walsh; D M Bell; C L Gala; S Hildreth; L G Ten Eyck; W J Hall
Journal:  N Engl J Med       Date:  1983-06-16       Impact factor: 91.245

  8 in total
  5 in total

1.  Aqueous Extracts of Hibiscus sabdariffa Calyces Decrease Hepatitis A Virus and Human Norovirus Surrogate Titers.

Authors:  Snehal S Joshi; Lezlee Dice; Doris H D'Souza
Journal:  Food Environ Virol       Date:  2015-07-05       Impact factor: 2.778

Review 2.  Direct-acting Antivirals and Host-targeting Agents against the Hepatitis A Virus.

Authors:  Tatsuo Kanda; Shingo Nakamoto; Shuang Wu; Masato Nakamura; Xia Jiang; Yuki Haga; Reina Sasaki; Osamu Yokosuka
Journal:  J Clin Transl Hepatol       Date:  2015-09-15

Review 3.  Viral hepatitis in 2021: The challenges remaining and how we should tackle them.

Authors:  Rebecca Dunn; Aaron Wetten; Stuart McPherson; Mhairi C Donnelly
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742

4.  Disseminated inflammation of the central nervous system associated with acute hepatitis E: a case report.

Authors:  Jan Rahmig; Arne Grey; Marco Berning; Jochen Schaefer; Martin Lesser; Heinz Reichmann; Volker Puetz; Kristian Barlinn; Timo Siepmann
Journal:  BMC Neurol       Date:  2020-10-27       Impact factor: 2.474

Review 5.  Hepatitis A: Epidemiology, High-Risk Groups, Prevention and Research on Antiviral Treatment.

Authors:  Marion Migueres; Sébastien Lhomme; Jacques Izopet
Journal:  Viruses       Date:  2021-09-22       Impact factor: 5.048

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.